Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer
Creators
- 1. University of Melbourne, Austin Hospital, Centre for PET, Heidelberg, Victoria (Australia)
- 2. University of Melbourne, Austin Hospital, Ludwig Institute for Cancer Research, Heidelberg, Victoria (Australia)
- 3. University of Melbourne, Austin Hospital, Department of Thoracic Surgery, Heidelberg, Victoria (Australia)
- 4. University of Melbourne, Austin Hospital, Department of Medicine, Heidelberg, Victoria (Australia)
- 5. Austin Hospital, Center for PET, Heidelberg, Victoria (Australia)
Description
18F-fluorodeoxyglucose positron emission tomography (FDG-PET) imaging is an important staging procedure in patients with non-small cell lung cancer (NSCLC). We aimed to demonstrate, through a decision tree model and the incorporation of real costs of each component, that routine FDG-PET imaging as a prelude to curative surgery will reduce requirements for routine mediastinoscopy and overall hospital costs. A decision tree model comparing routine whole-body FDG-PET imaging to routine staging mediastinoscopy was used, with baseline variables of sensitivity, specificity and prevalence of non-operable and metastatic disease obtained from institutional data and a literature review. Costings for hospital admissions for mediastinoscopy and thoracotomy of actual patients with NSCLC were determined. The overall and average cost of managing patients was then calculated over a range of FDG-PET costs to derive projected cost savings to the community. The prevalence of histologically proven mediastinal involvement in patients with NSCLC presenting for surgical assessment at our institution is 20%, and the prevalence of distant metastatic disease is 6%. Based on literature review, the pooled sensitivity and specificity of FDG-PET for detection of mediastinal spread are 84% and 89% respectively, and for mediastinoscopy, 81% and 100%. The average cost of mediastinoscopy for NSCLC in our institution is AUD$4,160, while that of thoracotomy is AUD$15,642. The cost of an FDG-PET scan is estimated to be AUD$1,500. Using these figures and the decision tree model, the average cost saving is AUD$2,128 per patient. Routine FDG-PET scanning with selective mediastinoscopy will save AUD$2,128 per patient and will potentially reduce inappropriate surgery. These cost savings remain robust over a wide range of disease prevalence and FDG-PET costs. (orig.)
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00259-005-1821-0Additional details
Identifiers
Publishing Information
- Journal Title
- European Journal of Nuclear Medicine and Molecular Imaging
- Journal Volume
- 32
- Journal Issue
- 9
- Journal Page Range
- p. 1033-1040
- ISSN
- 1619-7070
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 37000272
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARCINOMAS; COMPARATIVE EVALUATIONS; LUNGS; MEDIASTINUM; POSITRON COMPUTED TOMOGRAPHY
- Descriptors DEC
- BODY; CHEST; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; EMISSION COMPUTED TOMOGRAPHY; EVALUATION; NEOPLASMS; ORGANS; RESPIRATORY SYSTEM; TOMOGRAPHY